#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    T-cell type acute leukaemia Cutaneous T-cell lymphoma refractory Fusarium infection Post transplant lymphoproliferative disorder Ewing's sarcoma metastatic Skin cancer Autoimmune haemolytic anaemia Follicular lymphoma stage II Langerhans cell sarcoma Pemphigoid Neurodermatitis Small cell lung cancer Desmoplastic small round cell tumour Mantle cell lymphoma stage II Noonan syndrome More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Treatment Glycogen storage disease type II – Diagnostics Biotinidase deficiency – Diagnostics Focal segmental glomerulosclerosis – Diagnostics Shprintzen-Goldberg syndrome – Treatment Gaucher’s disease type III Adrenocortical carcinoma – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Basic Information Congenital nephrogenic diabetes insipidus – Treatment Lymphangiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Apl-101 GSKVX000000048110 Pegipanermin Crizotinib Ads-013 ZOREVUNERSEN SODIUM Protrans Retifanlimab Blinatumomab Aficamten Keto-Isoleucine Calcium Fexofenadine Lactose Monohydrate Mk-6194 Carfilzomib Pirtobrutinib S227928 Clonidine Hydrochloride Setrusumab Lithium Carbonate More therapies…

    Learn about Your Condition

    Idiopathic pulmonary fibrosis Gastrectomy Oesophagogastroscopy Femoral hernia Bladder cancer Chorea Mental disorder Circulatory collapse Type 1 diabetes mellitus Syphilis Monkeypox Brain abscess Cutibacterium acnes infection Premature baby Chronic hepatitis C More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rhabdomyosarcoma

  • Indocyanine Green and Near-Infrared Fluorescence for Lymph Node Removal in Children with Renal Tumours or Paratesticular Rhabdomyosarcoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Indocyanine Green
    The Netherlands

  • Study on the Safety and Effectiveness of Patritumab Deruxtecan for Children with Relapsed or Refractory Hepatoblastoma and Rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • 1,3-BUTYLENE GLYCOL
    • Cinchocaine Hydrochloride
    • Patritumab Deruxtecan
    Belgium Czechia Denmark France Germany Greece +6

  • Study to Find the Right Dose and Safety of Lutetium (177Lu) Edotreotide and Arginine-Lysine in Children with Somatostatin Receptor-Positive Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Central nervous system neoplasm
    • Neuroendocrine tumour
    • Peripheral primitive neuroectodermal tumour of soft tissue
    Investigated Drugs:
    • Lutetium (177Lu) Edotreotide
    • L-Arginine Hydrochloride
    • L-Lysine Hydrochloride
    France Italy Spain

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ttf-Ngr
    Germany

  • Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Cyclophosphamide
    • Dactinomycin
    • Doxorubicin
    Austria Belgium Czechia Denmark Finland France +10

  • Study of Crizotinib and Temsirolimus for Children with ALK, ROS1, or MET Positive Cancers, Including Neuroblastoma and Rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Anaplastic large cell lymphoma T- and null-cell types
    • Inflammatory myofibroblastic tumour
    • Neuroblastoma
    Investigated Drugs:
    • Temsirolimus
    • Crizotinib
    Denmark Finland France Germany Italy The Netherlands +3
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!